Pharmacokinetic Evaluation of Oral Levofloxacin in Human Immunodeficiency Virus-Infected Subjects Receiving Concomitant Antiretroviral Therapy

Lignende værker

• Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
  af: Chien, S C, et al.
  Udgivet: (1997)
• Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects
  af: Geller, David E., et al.
  Udgivet: (2011)
• Pharmacokinetics and Pharmacodynamics of Intravenous Levofloxacin at 750 Milligrams and Various Doses of Metronidazole in Healthy Adult Subjects
  af: Sprandel, Kelly A., et al.
  Udgivet: (2004)
• Pharmacokinetics and Safety of High-Dose and Extended-Interval Regimens of Levofloxacin in Human Immunodeficiency Virus-Infected Patients
  af: Piscitelli, Stephen C., et al.
  Udgivet: (1999)
• Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.
  af: Goodwin, S D, et al.
  Udgivet: (1994)